● Recruiting

Safety and Efficacy Study of Collagenase CNT201 Injection for Treatment of Dupuytren's Contracture

Condition: Dupuytren Contracture · Dupuytren Disease of Finger · Sponsor: CONNEXT

PhasePhase 1/Phase 2

Planned participants60

Who can joinAll sexes, 18 Years to 75 Years

Healthy volunteersNo

About this study

This trial is a multicenter, Phase 1/2, study to assess the safety, tolerability, efficacy, PK, and immunogenicity of CNT201 in adult participants with DC (Dupuytren's Contracture).

This description comes directly from the study's public registry record.

Talk to the study team

Suntae Kim · +82-10-5682-2489 · suntae.kim@connext.co.kr

Always discuss trial participation with your own doctor first.

Locations (1)

A R Houston Medical Pty Ltd.

Kippa-Ring, Queensland, Australia

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07640425